Neuroimaging plays a pivotal role in diagnosing and understanding Alzheimer's disease and dementia. Techniques such as MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), and CT (Computed Tomography) scans provide insights into brain structure, function, and pathology. MRI reveals structural changes like hippocampal atrophy, a hallmark of Alzheimer's. PET scans detect amyloid-beta plaques and tau tangles, proteins implicated in Alzheimer's progression. Functional MRI (fMRI) highlights brain activity patterns, aiding in understanding cognitive decline. These imaging tools not only assist in early diagnosis but also monitor disease progression and evaluate treatment efficacy. Ongoing research focuses on refining these techniques to enhance early detection accuracy and to track neurodegeneration more effectively, crucial steps towards developing therapies to manage and potentially halt Alzheimer's and dementia progression.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China